Is cancer of the external auditory canal more common in the bony portion or the cartilaginous portion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cancer of the External Auditory Canal: Location Distribution

In early-stage disease (T1-T2), squamous cell carcinoma involves both the cartilaginous and bony portions of the external auditory canal, while adenocarcinoma predominantly affects only the cartilaginous portion. 1

Location Patterns by Histologic Type

Squamous Cell Carcinoma (SCC)

  • Early-stage SCC (T1-T2) involves both cartilaginous and bony portions in the majority of cases (11/12 patients, 92%) 1
  • Advanced-stage SCC (T3-T4) demonstrates extensive bony involvement and invasion into adjacent tissues 1
  • SCC shows more aggressive local invasion patterns with parapharyngeal space involvement being significantly more common in recurrent disease (p = 0.02) 1

Adenocarcinoma (Including Adenoid Cystic Carcinoma)

  • Early-stage adenocarcinoma (T1-T2) is confined to the cartilaginous portion in all cases (6/6 patients, 100%) (p < 0.01 compared to SCC) 1
  • Advanced-stage adenocarcinoma (T3-T4) eventually extends to involve bony structures and adjacent tissues, similar to SCC 1
  • Adenoid cystic carcinoma of the external auditory canal demonstrates excellent local control with surgery plus postoperative radiotherapy, with 10-year local recurrence-free survival of 79.5% 2

Clinical Implications

Anatomic Considerations

The external auditory canal consists of an outer cartilaginous portion (outer two-thirds) and an inner bony portion (inner third that ends at the eardrum) 3

Metastatic Patterns

  • SCC preferentially metastasizes to lymph nodes (6/22 patients, 27%) 1
  • Adenocarcinoma shows distant lung metastasis even at early stages (5/19 patients, 26%; including 1/6 early-stage patients) 1
  • Regional lymph node failure is rare overall (3.3% in adenoid cystic carcinoma series) 2

Imaging Characteristics

  • Necrosis is significantly more common in SCC (9/10 patients, 90%) compared to adenocarcinoma (3/13 patients, 23%) (p = 0.02) 1
  • High-resolution CT and MRI are essential for evaluating tumor extent, with necrosis appearing as hypodensity on CT and hyperintense on T2-weighted MRI with heterogeneous enhancement 1

Important Caveats

Advanced-stage disease (T3-T4) obliterates the distinction between cartilaginous and bony involvement for both histologic types, as both demonstrate extensive bony destruction and adjacent tissue invasion 1. The location predilection is only clinically relevant in early-stage disease for predicting growth patterns and planning surgical approaches 1, 4.

The rarity of external auditory canal carcinoma (representing a small fraction of head and neck malignancies) makes prospective randomized trials challenging, and current management strategies rely heavily on retrospective case series and expert consensus 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current treatment strategies for external auditory canal cancer.

Japanese journal of clinical oncology, 2025

Research

The international expert consensus on management of external auditory canal carcinoma.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.